Document is current

Article History

First Online: 26 July 2018

Competing interests

: S.M. is a consultant for Chiasma, Ionis, Ipsen and Strongbridge Pharma and receives research grants from Pfizer. M.D.B. is a consultant for Ipsen and Novartis, a speakers bureau member for Ipsen and has received research grants from Novartis. P.C. has received unrestricted research and educational grants from Ipsen, Novartis and Pfizer as head of the Department of Endocrinology and Reproductive Diseases, Hôpitaux Universitaires Paris-Sud,has served as investigator for clinical trials funded by Antisense, Chiasma, Ipsen, Italpharmaco, Novartis and Pfizer and is a consultant for Ipsen, Novartis and Pfizer. All fees and honoraria are paid to his institution. A.K. is a consultant for Chiasma and Crinetics and has received research grants from Ipsen. F.F.C. is a speakers bureau member for Pfizer and has received research grants from Ipsen and Pfizer. C.J.S. is an advisory board member for Pfizer and a speakers bureau member for Pfizer and Ipsen. A.L. is a consultant for Ipsen and Novartis, a speakers bureau member for Ipsen, Novartis and Pfizer and has received research grants from Pfizer. D.R.C. is a consultant for Crinetics, Ipsen and Pfizer. A.G. is a consultant for Ipsen, Novartis and Pfizer. J.A.H.W. declares no competing interests.